Publications

2025

Efficacy of integrated social cognitive remediation vs neurocognitive remediation in schizophrenia: Results from the multicenter randomized controlled ISST (Integrated Social Cognition And Social Skills Therapy) study. Kamp D, Lowe A, Weide K, Riesbeck M, Bechdolf A, Leopold K, Brockhaus-Dumke A, Klos B, Hurlemann R, Wasserthal S, Muthesius A, Kambeitz J, Klingberg S, Hölz L, Hellmich M, Rosenberger KD, Sadura S, Meyer-Lindenberg A, Wölwer W. 2025 Feb 26;277:44-56. doi: 10.1016/j.schres.2025.02.015. Epub ahead of print. PMID: 40015077.

Vitrectomy with and without encircling band for pseudophakic retinal detachment: VIPER study report No. 4-long-term results.
Br J Ophthalmol 2025; 109(11): 1289-1294; Impact Factor=n.a.; Impact Factor 2024=3.5; Typ=Journal Article;Randomized Controlled Trial;Multicenter Study;
Baumgarten S, Hellmich M, Schiller P, Michalik C, Walter P, VIPER Study Group

Communication, Coordination, and Security for People With Multiple Sclerosis (COCOS-MS)
Dtsch Arztebl Int 2025; 122(18): ; Impact Factor=n.a.; Impact Factor 2024=7.2; Typ=
Golla H, Dunkl V, Dorr A, Goereci Y, Hellmich M, Warnke C, KOKOS MS Study Grp

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project. Salma Malik, Zoi Pana Dorothea, Christos D Argyropoulos, Sophia Themistocleous, Alan J Macken, Olena Valdenmaiier, Frank Scheckenbach, Elena Bardach, Andrea Pfeiffer, Katherine Loens, Jordi Cano Ochando, Oliver A Cornely, Jacques Demotes-Mainard, Sergio Contrino, Gerd Felder, JMIR Medical Informatics, Volume 13, 2025, ISSN 2291-9694, https://doi.org/10.2196/65590. (https://www.sciencedirect.com/science/article/pii/S2291969425000493)

2024

Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B). Stemler J, Yeghiazaryan L, Stephan C, Mohn KG, Carcas-Sansuan AJ, Rodriguez ER, Moltó J, Mitxeltorena IV, Welte T, Zablockienė B, Akova M, Bethe U, Heringer S, Salmanton-García J, Jeck J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA; EU-COVAT-1 AGED study group on behalf of the VACCELERATE consortium.  Int J Infect Dis. 2024 Sep;146:107161. doi: 10.1016/j.ijid.2024.107161. Epub 2024 Jul 9. PMID: 38992789.

Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paper. Bethe U, Pana ZD, Drosten C, Goossens H, König F, Marchant A, Molenberghs G, Posch M, Van Damme P, Cornely OA. Infection. 2024 Dec;52(6):2135-2144. doi: 10.1007/s15010-024-02347-1. Epub 2024 Jul 17. PMID: 39017997; PMCID: PMC11621139.

UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial. Wiedemann J, Hos D, Limburg E, Zettelmeyer U, Schiller P, Franklin J, Bachmann B, Böhringer D, Dietrich-Ntoukas T, Fuchsluger TA, Geerling G, Lang SJ, Mayer WJ, Priglinger S, Reinhard T, Seitz B, Cursiefen C.  Trials. 2024 Mar 6;25(1):169. doi: 10.1186/s13063-024-08011-1. PMID: 38448965; PMCID: PMC10916195.

"So at least now I know how to deal with things myself, what I can do if it gets really bad again"-experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study. BMC Health Serv Res 2024; 24(1): ; Impact Factor=3.0; Impact Factor 2024=3.0; Typ=Journal Article;
Müller A, Hebben F, Dillen K, Dunkl V, Goereci Y, Voltz R, Löcherbach P, Warnke C, Golla H, COCOS-MS trial group represented by Martin Hellmich

2021

Thalamic deep brain stimulation for Tourette Syndrome: A naturalistic trial with brief randomized, double-blinded sham-controlled periods
Brain Stimul. 2021 Jul 7;S1935-861X(21)00137-6.
doi: 10.1016/j.brs.2021.07.003. Online ahead of print.
Juan Carlos Baldermann, Jens Kuhn, Thomas Schüller, Sina Kohl, Pablo Andrade, Sophia Schleyken, Reinhild Prinz-Langenohl, Martin Hellmich, Michael T Barbe, Lars Timmermann, Veerle Visser-Vandewalle, Daniel Huys

2020

Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) - a prospective randomized controlled trial:Graefe's Archive for Clinical and Experimental Ophthalmology (2020) 258:869–878
Ira Seibel1; Daniela Vollhardt1; Aline I. Riechardt1; Matus Rehak1; Sabine Schmied; Petra Schiller3; Oliver Zeitz1;
Martin Hellmich3; Antonia M. Joussen1

The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II; BMC Cancer volume 20, Article number: 781 (2020)
Jessica M. Leers,Laura Knepper,Arjen van der Veen,Wolfgang Schröder,Hans Fuchs,Petra Schiller,Martin Hellmich,Ulrike Zettelmeyer,Lodewijk A. A. Brosens,Alexander Quaas,Jelle P. Ruurda,Richard van Hillegersberg & Christiane J. Bruns

Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection.
Trials 2020; 21(1): 175; Kaasch AJ, Rommerskirchen A, Hellmich M, Fätkenheuer G, Prinz-Langenohl R, Rieg S, Kern WV, Seifert H, SABATO trial group; J Antimicrob Chemother 2020; 75(3): 618-627; Cornely OA, Cisneros JM, Torre-Cisneros J, Rodrfguez-Hernandez MJ, Tall6n-Aguilar L, Calbo E, Horcajada JP, Queckenberg . Zettelmeyer U, Arenz  D, Rosso-Fernandez CM, Jimenez-Jorge  S, Turner G, Raber S, O'Brien S, Luckey A, COMBACTE-CARE consortium/REJUVENATE Study GrouR